Assessment of the Risk and the Prophylaxis of Venous Thromboembolism in Surgical Patients
Open Access
- 1 December 2003
- journal article
- review article
- Published by S. Karger AG in Pathophysiology of Haemostasis and Thrombosis
- Vol. 33 (5-6) , 358-361
- https://doi.org/10.1159/000083829
Abstract
This review article first deals with risk factors for developing postoperative venous thromboembolism. The various pharmacological prophylactic methods available today are summarized with focus on dominating method low molecular weight heparin and the two new ones, the Xa inhibitor fondaparinux and the IIa inhibitor ximelagatran, both approved in orthopaedic surgery. The optimal timing to start prophylaxis is between 2 hours before and 10 hours after surgery. Evidence is accumulating that some in risk groups prolonged prophylaxis is indicated, ie. elective hip surgery, probably hip fracture surgery and probably also patients operated on for abdominal/pelvic cancer.Keywords
This publication has 28 references indexed in Scilit:
- Duration of Prophylaxis Against Venous Thromboembolism With Fondaparinux After Hip Fracture SurgeryA Multicenter, Randomized, Placebo-Controlled, Double-blind StudyArchives of internal medicine (1960), 2003
- Extended Out-of-Hospital Low-Molecular-Weight Heparin Prophylaxis against Deep Venous Thrombosis in Patients after Elective Hip ArthroplastyAnnals of Internal Medicine, 2001
- Timing of Initial Administration of Low-Molecular-Weight Heparin Prophylaxis Against Deep Vein Thrombosis in Patients Following Elective Hip ArthroplastyArchives of internal medicine (1960), 2001
- Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trialsThe Lancet, 2001
- Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgeryBritish Journal of Surgery, 2001
- Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin Extended Out-of-Hospital vs In-Hospital Warfarin/Out-of-Hospital Placebo in Hip Arthroplasty PatientsArchives of internal medicine (1960), 2000
- Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: Update of previous meta-analysesBritish Journal of Surgery, 1997
- Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1996
- Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysisThe Lancet, 1992
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988